Virtual Library
Start Your Search
Karen Kelly
Author of
-
+
19 - Debate #3 Optimal Therapy After Progression on Osimertinib with No New Driver is Chemotherapy Alone (ID 19)
- Event: TTLC 2019
- Type: General Session
- Track:
- Presentations: 1
- Moderators:Ravi Salgia
- Coordinates: 2/22/2019, 18:05 - 18:20, Starlight Ballroom
-
+
No - Chemo + IO + Bev (ID 19.01)
18:05 - 18:20 | Author(s): Karen Kelly
- Abstract
Abstract not provided
-
+
22 - ICI Combinations (Stimulatory and Inhibitory) (ID 22)
- Event: TTLC 2019
- Type: General Session
- Track:
- Presentations: 1
- Moderators:Mary Redman, Yu Shyr
- Coordinates: 2/23/2019, 08:00 - 09:50, Starlight Ballroom
-
+
LYC55716 (RORgamma) (ID 22.18)
08:00 - 09:50 | Author(s): Karen Kelly
- Abstract
Abstract not provided